Holen Sie sich die Stockscreener-App
392.15
0.48%
-1.88
Handel nachbörslich:
391.09
-1.06
-0.27%
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Forum
Prognose
Aktiensplit
Dividendenhistorie
West Pharmaceutical Services Inc Aktie (WST) Neueste Nachrichten
West Pharmaceutical Services Inc Unsponsored Brazilian Depositary Receipt Repr 0.0285714 Sh - TradingView
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo! Finance Canada
West Pharmaceutical Services, I (WST) Stock Forecasts - Yahoo Finance
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
West Pharmaceutical Services (WST) Raises Quarterly Dividend by 18.2% - GuruFocus
West Pharmaceutical Services Raises Quarterly Dividend 18% to $0.26 a Share, Payable Nov. 18 to Holders as of Nov. 11. - marketscreener.com
West Declares Quarterly Dividend - PR Newswire
A company has raised its dividend for 34 straight years. Its next payment is $0.26 per share. - Stock Titan
Press Release: West Declares Quarterly Dividend - Moomoo
3 Low-Volatility Stocks We’re Skeptical Of - FinancialContent
West Pharmaceutical Sets October 29 Earnings Release - MyChesCo
West Pharmaceutical Services (NYSE:WST): What Does the S&P 500 Context Reveal? - Kalkine Media
West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com South Africa
West Pharmaceutical Services stock hits 52-week high at $386.08 - Investing.com
West Pharmaceutical Services stock hits 52-week high at $386.08 By Investing.com - Investing.com Nigeria
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
West Pharmaceutical Services Inc. stock underperforms Thursday when compared to competitors despite daily gains - MarketWatch
What Do West Pharmaceutical Services' Latest Results Reveal About This S&P 500 Stock (NYSE:WST)? - Kalkine Media
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? - TradingView
West Pharmaceutical Stock Gains 36.1% YTD: What's Behind the Rally? - Yahoo Finance
Meta, JPMorgan, West Pharmaceutical And More: CNBC’s ‘Final Trades’ - Benzinga
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Here's Why You Should Retain DexCom Stock in Your Portfolio for Now - Zacks Investment Research
Veeva Systems' Basics Gains Traction With 175+ Emerging Biotech Firms - Zacks Investment Research
TD Cowen Adjusts Price Target on West Pharmaceutical Services to $420 From $410 - Yahoo Finance
ANGO Q1 Earnings Beat Estimates on Med Tech Growth, Revenues Up Y/Y - Zacks Investment Research
Reasons to Hold Veeva Systems Stock in Your Portfolio for Now - Zacks Investment Research
Smith+Nephew Launches CARTIHEAL Implant Across Key European Markets - Zacks Investment Research
Here's Why You Should Retain WAT Stock in Your Portfolio for Now - Zacks Investment Research
Third-quarter results are due before markets open Oct. 29; West Pharmaceutical's call follows at 8 a.m. - Stock Titan
West Pharmaceutical Services Needs Faster Earnings Growth To Justify Its Price (NYSE:WST) - Seeking Alpha
West Pharmaceutical Services (WST) Stock Could Be 17% Overvalued As Cash Flow Falls Short - Yahoo Finance
West Pharmaceutical Services Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Reasons to Retain Fresenius Medical Stock in Your Portfolio for Now - Zacks Investment Research
BDX Expands U.S. Manufacturing With $19B Healthcare Investment - Zacks Investment Research
Reasons to Hold HealthEquity Stock in Your Portfolio for Now - Zacks Investment Research
Veeva's DQS Scales Data Automation Across 1,000+ Clinical Studies - Zacks Investment Research
West Pharmaceutical: Still A Buy, But Expectations Are Rising - Seeking Alpha
PCR Packaging For Pharma And Otc Market 7.2% CAGR to 2035 on ESG MandatesNews and Statistics - IndexBox
GE HealthCare Expands U.S. PET Radiopharma Reach With SOFIE Deal - TradingView
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - Zacks Investment Research
Reasons to Retain Cardinal Health Stock in Your Portfolio for Now - TradingView
Barclays Raises West Pharmaceutical Services Price Target to $440 From $400, Maintains Overweight Rating - marketscreener.com
West Pharmaceutical Services Highlights Leadership & Expertise - Contract Pharma
Is West Pharmaceutical Services Inc (WST) Overvalued After 3.2% - GuruFocus
West Pharmaceutical Services Inc. stock outperforms competitors on strong trading day - MarketWatch
Reasons to Retain Doximity Stock in Your Portfolio for Now - Zacks Investment Research
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - Yahoo Finance
What to Expect From West Pharmaceutical Services' Next Quarterly Earnings Report - inkl
2.26%
0.82%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):